CNTA

Centessa Pharmaceuticals
CNTA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$38
30% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Guggenheim
Guggenheim
Debjit Chattopadhyay
75% 1-yr CNTA win rate
18 Nov ‘25 12 days ago
Wells Fargo
Wells Fargo
Benjamin Burnett
100% 1-yr CNTA win rate
13 Nov ‘25 17 days ago
Stephens & Co
Stephens & Co
Sudan Loganathan
100% 1-yr CNTA win rate
28 Oct ‘25 1 month ago